A detailed history of Global Trust Asset Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 474 shares of IONS stock, worth $15,860. This represents 0.01% of its overall portfolio holdings.

Number of Shares
474
Previous 474 -0.0%
Holding current value
$15,860
Previous $22,000 18.18%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023

BUY
$38.5 - $47.13 $2,887 - $3,534
75 Added 18.8%
474 $21,000
Q1 2021

Apr 14, 2021

BUY
$42.51 - $63.78 $16,961 - $25,448
399 New
399 $18,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.75B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Global Trust Asset Management, LLC Portfolio

Follow Global Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.